Last reviewed · How we verify
NCT05101863: MOTIVFOOD
FMRI of Dietary Decision-making in Food Addicted Participants Compared to Non-food Addicted Participants
trial testing Motivational interviewing in Food Addiction, Obesity, fMRI, Decision-making, Motivational Interviewing in 56 participants. Completed in 13 October 2024.
13 September 2024
Quick facts
| Lead sponsor | Institut National de la Santé Et de la Recherche Médicale, France |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 56 |
| Start date | 15 September 2022 |
| Primary completion | 13 September 2024 |
| Estimated completion | 13 October 2024 |
| Sites | 1 location across France |
Drugs / interventions tested
- Motivational interviewing
Conditions studied
- Food Addiction, Obesity, fMRI, Decision-making, Motivational Interviewing — all drugs for Food Addiction, Obesity, fMRI, Decision-making, Motivational Interviewing →
Sponsor
Institut National de la Santé Et de la Recherche Médicale, France — full company profile →
Who can join
Adults 18 to 70, any sex, with Food Addiction, Obesity, fMRI, Decision-making, Motivational Interviewing. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Why in some situations can words soothe our cravings? This research proposal will test the power of self-generated reasons for behavioural change in food addiction, which concerns about three out of ten persons and causes major life hazards such as obesity, diabetes and cancer. While food addiction is becoming more and more frequent in western societies, not much is known about its underlying neurocognitive mechanisms and how to tackle it. This study aims to investigate if and why certain types of affirmation-based therapies such as motivational interviewing (MI) are beneficial for the treatment of food addiction. The working hypothesis proposes that cognitive regulation-based self-control underpins the neurocognitive shift of a patient's willingness to change addictive behaviour, generated by the patient during MI therapy of food addiction. To test this hypothesis this study combines functional magnetic resonance imaging with behavioural testing of dietary decision-making following a participant's change or sustain talk statements. It will compare three groups of participants with and without food addiction and obesity and lean controls. This study will contribute to the improvement of therapies based upon talking oneself in and out of addiction promoting goals. Findings will provide a better understanding of how our everyday life dietary decision-environments prompt good intentions such as improving long-term nutritional quality to actual behaviours such as forgoing immediate desire.
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
-
The neural pathways of change: an fMRI study of the effects of behavioral change suggestions on value-based dietary decision-making.
Rodrigues B, Flament B, Khalid I, Rampanana M, et al · · 2026 · PMID 41667838 · DOI 10.1038/s41366-026-02018-1 -
The neural pathways of change: An fMRI study of the effects of behavioral change suggestions on value-based dietary decision-making
Rodrigues B, Flament B, Khalid I, Rampanana M, et al · · 2025 · DOI 10.1101/2025.03.03.25323231 -
How motivational interviewing shifts food choices and craving-related brain responses to healthier options
Rodrigues B, Khalid I, Frileux S, Flament B, et al · · 2023 · DOI 10.1101/2023.10.13.562241
Verify or expand the search:
- PubMed search for NCT05101863
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Motivational interviewing
Trials testing the same drug.
- NCT07451496 — PRecision gerOMedicinE: Tailored Healthy agEing With Lifestyle, sUpplements and drugS (PROMETHEUS) · NA · recruiting
- NCT06972030 — Motivational Interviewing-Based Training · NA · not yet recruiting
- NCT06781216 — Effect of Motivational Interviewing on Posttraumatic Stress Symptoms and Posttraumatic Growth in Women with Endometrial · NA · not yet recruiting
- NCT06635460 — Motivational Interviewing and WhatsApp-Based Monitoring for Metabolic Control and Self-Efficacy in Adolescents With T1DM · NA · not yet recruiting
- NCT06583356 — Motivational Interviewing Intervention For Risky Drinking Treatment Among Indigenous Population · Phase 1, PHASE2 · not yet recruiting
Other Institut National de la Santé Et de la Recherche Médicale, France trials
Trials by the same sponsor.
- NCT07311213 — GENES AND AUTISM - IPSC · NA · not yet recruiting
- NCT07063719 — Identification of Cellular Biomarkers of Rare Eye Diseases in Adults · NA · not yet recruiting
- NCT06906042 — Multimodal Cardiovascular and Hepatic Population Imaging · recruiting
- NCT06951035 — Impact of rTMS on BCI Control in Upper Limb Motor Rehabilitation of Patients With Chronic Stroke · NA · not yet recruiting
- NCT06660108 — MOLECULAR BASIS OF LANGUAGE DEVELOPMENT AND ASSOCIATED DISORDERS · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05101863 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Institut National de la Santé Et de la Recherche Médicale, France
- Last refreshed: 12 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05101863.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing